A meta-analysis to compare Dacron versus polytetrafluoroethylene grafts for above-knee femoropopliteal bypass. J Vasc Surg 2014; 60: 506-515.
Published: 18th December 2014
Authors: Rychlik IJ, Davey P, Murphy J, O'Donnell ME
The study included 1192 procedures. Primary patency after one year was similar for Dacron compared to PTFE (relative risk 0.78, P=0.08). After five years, Dacron was superior (0.79, P=0.003).Pubmed Link
You may also be interested in
Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection. The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial final results. JAMA Neurol 2019; 76: 657-664.
Authors: Markus HS, Levi C, King A, Madigan J, Norris J, et al. for the et al.
Optimal antiplatelet therapy in moderate to severe asymptomatic carotid stenosis: a comprehensive review of the literature. Eur J Vasc Endovasc Surg 2019; 57: 199-211.
Authors: Murphy SJ, Naylor AR, Ricco J-B, Sillesen H, Kakkos S, Halliday H et al.
A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg 2018; 68: 1744-1752.
Authors: Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B et al.
Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 2019; 380: 1305-1315.
Authors: Arabi YM, Al-Hameed F, Burns KEA, Mehta S, Alsolamy SJ, Alshahrani MS et al.
A randomized trial of class 2 and class 3 elastic compression in the prevention of recurrence of venous ulceration. J Vacs Surg Venous Lymphat Disord 2018; 6: 717–723.
Authors: Milic DJ, Zivic SS, Bogdanovic DC, Golubovic MD, Lazarevic MV, Lazarevic KK et al.
A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. J Vasc Surg 2018; 68: 1241–1256.
Authors: Texakalidis P, Giannopoulos S, Charisis N, Giannopoulos S, Karasavvidis T, Koullias G et al.
Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vas Venous Lymphatic Disorders 2018; 6: 606–613.
Authors: Gibson K, Morrison N, Kolluri R, Vasquez M, Weiss R, Cher D et al.
Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials. Surgery 2018; 164: 1234-1240.
Authors: Rausa E, Kelly ME, Asti E, Aiolfi A, Bonitta G, Winter DC et al.
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med 2019; 380: 720-728.
Authors: Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T et al.
Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med 2019; 380: 711-719.
Authors: Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A et al.
A randomized clinical trial of buffered tumescent local anaesthesia during endothermal ablation for superficial venous incompetence. Eur J Vasc Endovasc Surg 2018; 56: 699-708.
Authors: Nandhra S, Wallace T, El-Sheikha J, Leun C, Carradice D, Chetter I et al.
Management of extremity fasciotomy sites prospective randomized evaluation of two techniques. Am J Surg 2018; 216: 736–739.
Authors: Johnson LS, Chaar M, Ball CG, Perez S, Nicholas JM, Wyrzykowski AD et al.